Systemic lupus erythematosus and infections: Clinical importance of conventional and upcoming biomarkers

Autoimmunity Reviews

Volumn 12, Issue 2, 2012, Pages 157-163

  Sciascia, S ^a,b   Ceberio, L ^c   Garcia Fernandez, C ^d   Roccatello, D ^b   Karim, Y ^e   Cuadrado, M J ^e  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF TURIN   (Italy)

^c HOSPITAL TXAGORRITXU   (Spain)

^d Medicina Interna   (Spain)

^e ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Biomarkers; Infection; Systemic lupus erythematosus

Indexed keywords

BIOLOGICAL MARKER; CALGRANULIN A; CALGRANULIN B; CD27 ANTIGEN; CD64 ANTIGEN; CXCL13 CHEMOKINE; DOUBLE STRANDED DNA ANTIBODY; PROCALCITONIN;

ERYTHROCYTE SEDIMENTATION RATE; HUMAN; INFECTION; MEDICAL DECISION MAKING; PHAGOCYTE; PROTEIN EXPRESSION; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; URINALYSIS;

BIOLOGICAL MARKERS; COMMUNICABLE DISEASES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 84870248328     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2012.03.009     Document Type: Review

References (55)

1. Juarez M., Misischia R., Alarcon G.S. Infections in systemic connective tissue diseases: systemic lupus erythematosus, scleroderma, and polymyositis/dermatomyositis. Rheum Dis Clin North Am 2003, 29:163-184.
2. Zandman-Goddard G., Shoenfeld Y. Infections and SLE. Autoimmunity 2005, 38:473-485.
3. Ramos-Casals M. Viruses and lupus: the viral hypothesis. Lupus 2008, 17:163-165.
4. Ramos-Casals M., Cuadrado M.J., Alba P., Sanna G., Brito-Zeron P., Bertolaccini L., et al. Acute viral infections in patients with systemic lupus erythematosus: description of 23 cases and review of the literature. Medicine (Baltimore) 2008, 87:311-318.
5. Linnik M.D., Hu J.Z., Heilbrunn K.R., Strand V., Hurley F.L., Joh T. Relationship between anti-double-stranded DNA antibodies and exacerbation of renal disease in patients with systemic lupus erythematosus. Arthritis Rheum 2005, 52:1129-1137.
6. Valentijn R.M., van Overhagen H., Hazevoet H.M., Hermans J., Cats A., Daha M.R., et al. The value of complement and immune complex determinations in monitoring disease activity in patients with systemic lupus erythematosus. Arthritis Rheum 1985, 28:904-913.
7. Marto N., Bertolaccini M.L., Calabuig E., Hughes G.R., Khamashta M.A. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus. Ann Rheum Dis 2005, 64:444-448.
8. Muller B., Peri G., Doni A., Perruchoud A.P., Landmann R., Pasqualini F., et al. High circulating levels of the IL-1 type II decoy receptor in critically ill patients with sepsis: association of high decoy receptor levels with glucocorticoid administration. J Leukoc Biol 2002, 72:643-649.
9. Birmingham D.J., Irshaid F., Nagaraja H.N., Zou X., Tsao B.P., Wu H., et al. The complex nature of serum C3 and C4 as biomarkers of lupus renal flare. Lupus 2010, 19:1272-1280.
10. Firooz N., Albert D.A., Wallace D.J., Ishimori M., Berel D., Weisman M.H. High-sensitivity C-reactive protein and erythrocyte sedimentation rate in systemic lupus erythematosus. Lupus 2011, 20:588-597.
11. Gabay C., Roux-Lombard P., de Moerloose P., Dayer J.M., Vischer T., Guerne P.A. Absence of correlation between interleukin 6 and C-reactive protein blood levels in systemic lupus erythematosus compared with rheumatoid arthritis. J Rheumatol 1993, 20:815-821.
12. Kim H.A., Jeon J.Y., An J.M., Koh B.R., Suh C.H. C-reactive protein is a more sensitive and specific marker for diagnosing bacterial infections in systemic lupus erythematosus compared to S100A8/A9 and procalcitonin. J Rheumatol 2012, 39:728-734.
13. Mochizuki T., Aotsuka S., Satoh T. Clinical and laboratory features of lupus patients with complicating pulmonary disease. Respir Med 1999, 93:95-101.
14. Moutsopoulos H.M., Mavridis A.K., Acritidis N.C., Avgerinos P.C. High C-reactive protein response in lupus polyarthritis. Clin Exp Rheumatol 1983, 1:53-55.
15. Amezcua-Guerra L.M., Springall R., Arrieta-Alvarado A.A., Rodriguez V., Rivera-Martinez E., Castillo-Martinez D., et al. C-reactive protein and complement components but not other acute-phase reactants discriminate between clinical subsets and organ damage in systemic lupus erythematosus. Clin Lab 2011, 57:607-613.
16. Pepys M.B., Hirschfield G.M. C-reactive protein: a critical update. J Clin Invest 2003, 111:1805-1812.
17. Jackish J.G., McCune J. Comparison of ESR (erythrocyte sedimentation rate) and CRP (C-reactive protein) in lupus patients presenting with fever. American College of Rheumatology Annual meeting 2006, Abstract.
18. Vila L.M., Alarcon G.S., McGwin G., Bastian H.M., Fessler B.J., Reveille J.D. Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXIX. Elevation of erythrocyte sedimentation rate is associated with disease activity and damage accrual. J Rheumatol 2005, 32:2150-2155.
19. Christ-Crain M., Stolz D., Bingisser R., Muller C., Miedinger D., Huber P.R., et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med 2006, 174:84-93.
20. Tang B.M., Eslick G.D., Craig J.C., McLean A.S. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 2007, 7:210-217.
21. Eberhard O.K., Haubitz M., Brunkhorst F.M., Kliem V., Koch K.M., Brunkhorst R. Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection. Arthritis Rheum 1997, 40:1250-1256.
22. Lanoix J.P., Bourgeois A.M., Schmidt J., Desblache J., Salle V., Smail A., et al. Serum procalcitonin does not differentiate between infection and disease flare in patients with systemic lupus erythematosus. Lupus 2011, 20:125-130.
23. Quintana G., Medina Y.F., Rojas C., Fernandez A., Restrepo J.F., Rondon F., et al. The use of procalcitonin determinations in evaluation of systemic lupus erythematosus. J Clin Rheumatol 2008, 14:138-142.
24. Buhaescu I., Yood R.A., Izzedine H. Serum procalcitonin in systemic autoimmune diseases - where are we now?. Semin Arthritis Rheum 2010, 40:176-183.
25. Amour J., Birenbaum A., Langeron O., Le Manach Y., Bertrand M., Coriat P., et al. Influence of renal dysfunction on the accuracy of procalcitonin for the diagnosis of postoperative infection after vascular surgery. Crit Care Med 2008, 36:1147-1154.
26. Tamaki K., Kogata Y., Sugiyama D., Nakazawa T., Hatachi S., Kageyama G., et al. Diagnostic accuracy of serum procalcitonin concentrations for detecting systemic bacterial infection in patients with systemic autoimmune diseases. J Rheumatol 2008, 35:114-119.
27. Cameron J.S. Lupus nephritis. J Am Soc Nephrol 1999, 10:413-424.
28. Christopher-Stine L., Siedner M., Lin J., Haas M., Parekh H., Petri M., et al. Renal biopsy in lupus patients with low levels of proteinuria. J Rheumatol 2007, 34:332-335.
29. Houssiau F.A. Management of lupus nephritis: an update. J Am Soc Nephrol 2004, 15:2694-2704.
30. Duffy K.N., Duffy C.M., Gladman D.D. Infection and disease activity in systemic lupus erythematosus: a review of hospitalized patients. J Rheumatol 1991, 18:1180-1184.
31. Formiga Perez F., Moga Sampere I., Canet Gonzalez R., Pac Ferraz M., Mitjavila Villero F., Fernandez Nogues F. Infection and systemic lupus erythematosus: analysis of a series of 145 patients. Rev Clin Esp 1993, 193:105-109.
32. Skopouli F.N. Kidney injury in Sjogren's syndrome. Nephrol Dial Transplant 2001, 6:63-64.
33. Davis B.H. Improved diagnostic approaches to infection/sepsis detection. Expert Rev Mol Diagn 2005, 5:193-207.
34. Francis J., Barrett S.P., Ogilvie M.M., Sutherland S. Best Practice No 175. Guidelines for virological and non-viral serological examination of specimens in routine diagnostic microbiological laboratories. J Clin Pathol 2004, 57:1-5. 57.
35. Hussein O.A., El-Toukhy M.A., El-Rahman H.S. Neutrophil CD64 expression in inflammatory autoimmune diseases: its value in distinguishing infection from disease flare. Immunol Invest 2010, 39:699-712.
36. Jacobi A.M., Odendahl M., Reiter K., Bruns A., Burmester G.R., Radbruch A., et al. Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus. Arthritis Rheum 2003, 48:1332-1342.
37. Dorner T., Lipsky P.E. Correlation of circulating CD27high plasma cells and disease activity in systemic lupus erythematosus. Lupus 2004, 13:283-289.
38. Kim J., Koh J.K., Lee E.Y., Park J.A., Kim H.A., Lee E.B., et al. Serum levels of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) and pentraxin 3 (PTX3) as markers of infection in febrile patients with systemic lupus erythematosus. Clin Exp Rheumatol 2009, 27:773-778.
39. Schiffer L., Kielstein J.T., Haubitz M., Luhrs H., Witte T., Haller H., et al. Elevation of serum CXCL13 in SLE as well as in sepsis. Lupus 2011, 20:507-511.
40. Ye S., Guo Q., Tang J.P., Yang C.D., Shen N., Chen S.L. Could 2'5'-oligoadenylate synthetase isoforms be biomarkers to differentiate between disease flare and infection in lupus patients? A pilot study. Clin Rheumatol 2007, 26:186-190.
41. Allen E., Bakke A.C., Purtzer M.Z., Deodhar A. Neutrophil CD64 expression: distinguishing acute inflammatory autoimmune disease from systemic infections. Ann Rheum Dis 2002, 61:522-525.
42. Hoffmeyer F., Witte K., Schmidt R.E. The high-affinity Fc gamma RI on PMN: regulation of expression and signal transduction. Immunology 1997, 92:544-552.
43. Buckle A.M., Hogg N. The effect of IFN-gamma and colony-stimulating factors on the expression of neutrophil cell membrane receptors. J Immunol 1989, 143:2295-2301.
44. Ten Boekel E., Siegert C.E., Vrielink G.J., Van Dam V.C., Ceelen A., De Kieviet W. Analyses of CD27++ plasma cells in peripheral blood from patients with bacterial infections and patients with serum antinuclear antibodies. J Clin Immunol 2007, 27:467-476.
45. Yang D.H., Chang D.M., Lai J.H., Lin F.H., Chen C.H. Significantly higher percentage of circulating CD27(high) plasma cells in systemic lupus erythematosus patients with infection than with disease flare-up. Yonsei Med J 2010, 51:924-931.
46. Preble O.T., Rothko K., Klippel J.H., Friedman R.M., Johnston M.I. Interferon-induced 2'-5' adenylate synthetase in vivo and interferon production in vitro by lymphocytes from systemic lupus erythematosus patients with and without circulating interferon. J Exp Med 1983, 157:2140-2146.
47. Baechler E.C., Batliwalla F.M., Karypis G., Gaffney P.M., Ortmann W.A., Espe K.J., et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 2003, 100:2610-2615.
48. Ye S., Pang H., Gu Y.Y., Hua J., Chen X.G., Bao C.D., et al. Protein interaction for an interferon-inducible systemic lupus associated gene, IFIT1. Rheumatology (Oxford) 2003, 421:1155-1163.
49. Soyfoo M.S., Roth J., Vogl T., Pochet R., Decaux G. Phagocyte-specific S100A8/A9 protein levels during disease exacerbations and infections in systemic lupus erythematosus. J Rheumatol 2009, 36:2190-2194.
50. Chen Y.S., Yan W., Geczy C.L., Brown M.A., Thomas R. Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis. Arthritis Res Ther 2009, 11:R39.
51. Schiffer L., Kumpers P., Davalos-Misslitz A.M., Haubitz M., Haller H., Anders H.J., et al. B-cell-attracting chemokine CXCL13 as a marker of disease activity and renal involvement in systemic lupus erythematosus (SLE). Nephrol Dial Transplant 2009, 24:3708-3712.
52. Breitfeld D., Ohl L., Kremmer E., Ellwart J., Sallusto F., Lipp M., et al. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J Exp Med 2000, 192:1545-1552.
53. Shin K.C., Lee Y.J., Kang S.W., Baek H.J., Lee E.B., Kim H.A., et al. Serum procalcitonin measurement for detection of intercurrent infection in febrile patients with SLE. Ann Rheum Dis 2001, 60:988-989.
54. Chen H.S., Tsai W.P., Leu H.S., Ho H.H., Liou L.B. Invasive fungal infection in systemic lupus erythematosus: an analysis of 15 cases and a literature review. Rheumatology (Oxford) 2007, 46:539-544.
55. Ljungman P. Risk assessment in haematopoietic stem cell transplantation: viral status. Best Pract Res Clin Haematol 2007, 20:209-217.